BTR Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$10.5M Sell
223,165
-2,135
-0.9% -$111K 1.64% 24
2022
Q2
$11.4M Sell
225,300
-1,211
-0.5% -$66K 1.63% 25
2022
Q1
$13.8M Buy
226,511
+545
+0.2% +$32.5K 1.7% 24
2021
Q4
$14.9M Sell
225,966
-5,044
-2% -$323K 1.68% 23
2021
Q3
$14.5M Sell
231,010
-2,180
-0.9% -$139K 1.8% 23
2021
Q2
$14M Buy
233,190
+432
+0.2% +$25K 1.75% 24
2021
Q1
$12.8M Buy
232,758
+558
+0.2% +$30.9K 1.87% 21
2020
Q4
$12.7M Sell
232,200
-3,390
-1% -$177K 1.98% 19
2020
Q3
$11.8M Sell
235,590
-7,140
-3% -$346K 2.08% 17
2020
Q2
$10.7M Sell
242,730
-3,102
-1% -$133K 2.01% 19
2020
Q1
$9.23M Sell
245,832
-13,686
-5% -$576K 2.04% 18
2019
Q4
$11.4M Sell
259,518
-1,110
-0.4% -$46.7K 1.97% 18
2019
Q3
$10.7M Sell
260,628
-7,584
-3% -$310K 2.02% 17
2019
Q2
$10.8M Sell
268,212
-2,214
-0.8% -$83.8K 2.01% 17
2019
Q1
$10.4M Sell
270,426
-5,292
-2% -$192K 2.01% 16
2018
Q4
$9.18M Sell
275,718
-8,334
-3% -$289K 1.93% 19
2018
Q3
$10.8M Sell
284,052
-9,264
-3% -$329K 1.87% 21
2018
Q2
$9.81M Sell
293,316
-10,470
-3% -$341K 1.89% 20
2018
Q1
$9.37M Sell
303,786
-6,720
-2% -$207K 1.87% 19
2017
Q4
$8.98M Sell
310,506
-5,958
-2% -$172K 1.76% 22
2017
Q3
$8.81M Sell
316,464
-6,156
-2% -$170K 1.8% 22
2017
Q2
$8.96M Sell
322,620
-12,330
-4% -$326K 1.84% 21
2017
Q1
$8.45M Buy
334,950
+12,144
+4% +$294K 1.77% 23
2016
Q4
$7.82M Hold
322,806
1.75% 21
2016
Q3
$7.82M Sell
322,806
-35,880
-10% -$854K 1.75% 21
2016
Q2
$8.1M Sell
358,686
-2,760
-0.8% -$59.8K 1.86% 17
2016
Q1
$7.38M Sell
361,446
-53,814
-13% -$1.04M 1.72% 21
2015
Q4
$8.48M Buy
415,260
+6,756
+2% +$135K 1.93% 17
2015
Q3
$7.58M Sell
408,504
-5,700
-1% -$115K 1.81% 16
2015
Q2
$8.27M Buy
414,204
+6,330
+2% +$127K 1.95% 17
2015
Q1
$8.18M Sell
407,874
-10,566
-3% -$206K 1.98% 15
2014
Q4
$7.89M Sell
418,440
-9,120
-2% -$165K 2.15% 16
2014
Q3
$7.08M Buy
427,560
+6,360
+2% +$108K 1.96% 20
2014
Q2
$7.16M Sell
421,200
-2,610
-0.6% -$42.7K 1.97% 19
2014
Q1
$6.98M Sell
423,810
-9,720
-2% -$156K 2.03% 17
2013
Q4
$6.71M Sell
433,530
-10,650
-2% -$159K 1.91% 17
2013
Q3
$6.27M Sell
444,180
-14,280
-3% -$196K 1.97% 15
2013
Q2
$6M Buy
+458,460
New +$5.94M 1.87% 18

Other funds holding IHI

BTR Capital Management's IHI Position: Q3 2022 in Review

BTR Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 0.95% in Q3 2022, selling an estimated $111K and leaving 223,165 shares worth $10.5M. The position accounts for 1.64% of the portfolio, ranked #24.

BTR Capital Management first reported a position in IHI in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.9M in Q4 2021. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • BTR Capital Management held 223,165 shares of iShares US Medical Devices ETF worth $10.5M as of Q3 2022.
  • BTR Capital Management sold 2,135 iShares US Medical Devices ETF shares in Q3 2022, an estimated $111K.
  • iShares US Medical Devices ETF made up 1.64% of BTR Capital Management's portfolio in Q3 2022, its #24 holding.
  • BTR Capital Management first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 38 quarters since.
  • BTR Capital Management's iShares US Medical Devices ETF position peaked at $14.9M in Q4 2021.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.